Global Antibody-drug Conjugate (ADC) Payload Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Antibody-drug Conjugate (ADC) Payload market size was valued at US$ 1813 million in 2024 and is forecast to a readjusted size of USD 3041 million by 2031 with a CAGR of 8.3% during review period.
Antibody-drug Conjugate (ADC) Payload refers to a cytotoxic drug or bioactive molecule that is bound to an antibody. This payload is a key component of the ADC and is responsible for exerting an anti-tumor effect in the target cell to achieve a therapeutic effect. The design and selection of the payload directly affects the therapeutic effect and safety of the ADC and is an important part of achieving targeted therapy.
This report is a detailed and comprehensive analysis for global Antibody-drug Conjugate (ADC) Payload market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antibody-drug Conjugate (ADC) Payload market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Antibody-drug Conjugate (ADC) Payload market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Antibody-drug Conjugate (ADC) Payload market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Antibody-drug Conjugate (ADC) Payload market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody-drug Conjugate (ADC) Payload
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody-drug Conjugate (ADC) Payload market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Veranova, Merck, Cerbios-Pharma SA, Porton Pharma Solutions, Ajinomoto Bio-Pharma, Teva Pharmaceutical Industries Ltd., Abzena, Sterling Pharma Solutions Limited, Indena, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Antibody-drug Conjugate (ADC) Payload market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody-drug Conjugate (ADC) Payload product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antibody-drug Conjugate (ADC) Payload, with price, sales quantity, revenue, and global market share of Antibody-drug Conjugate (ADC) Payload from 2020 to 2025.
Chapter 3, the Antibody-drug Conjugate (ADC) Payload competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody-drug Conjugate (ADC) Payload breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Antibody-drug Conjugate (ADC) Payload market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antibody-drug Conjugate (ADC) Payload.
Chapter 14 and 15, to describe Antibody-drug Conjugate (ADC) Payload sales channel, distributors, customers, research findings and conclusion.
Antibody-drug Conjugate (ADC) Payload refers to a cytotoxic drug or bioactive molecule that is bound to an antibody. This payload is a key component of the ADC and is responsible for exerting an anti-tumor effect in the target cell to achieve a therapeutic effect. The design and selection of the payload directly affects the therapeutic effect and safety of the ADC and is an important part of achieving targeted therapy.
This report is a detailed and comprehensive analysis for global Antibody-drug Conjugate (ADC) Payload market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antibody-drug Conjugate (ADC) Payload market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Antibody-drug Conjugate (ADC) Payload market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Antibody-drug Conjugate (ADC) Payload market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Antibody-drug Conjugate (ADC) Payload market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody-drug Conjugate (ADC) Payload
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody-drug Conjugate (ADC) Payload market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Veranova, Merck, Cerbios-Pharma SA, Porton Pharma Solutions, Ajinomoto Bio-Pharma, Teva Pharmaceutical Industries Ltd., Abzena, Sterling Pharma Solutions Limited, Indena, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Antibody-drug Conjugate (ADC) Payload market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Tumor Specificity
- Broadly Targeted
- Pharmaceuticals
- Scientific Research
- Lonza
- Veranova
- Merck
- Cerbios-Pharma SA
- Porton Pharma Solutions
- Ajinomoto Bio-Pharma
- Teva Pharmaceutical Industries Ltd.
- Abzena
- Sterling Pharma Solutions Limited
- Indena
- Pfizer
- CordenPharma
- Heraeus Precious Metals
- Novasep
- Shanghai Haoyuan Chemexpress Co. Ltd.
- Minakem
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody-drug Conjugate (ADC) Payload product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antibody-drug Conjugate (ADC) Payload, with price, sales quantity, revenue, and global market share of Antibody-drug Conjugate (ADC) Payload from 2020 to 2025.
Chapter 3, the Antibody-drug Conjugate (ADC) Payload competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody-drug Conjugate (ADC) Payload breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Antibody-drug Conjugate (ADC) Payload market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antibody-drug Conjugate (ADC) Payload.
Chapter 14 and 15, to describe Antibody-drug Conjugate (ADC) Payload sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Tumor Specificity
1.3.3 Broadly Targeted
1.4 Market Analysis by Application
1.4.1 Overview: Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceuticals
1.4.3 Scientific Research
1.5 Global Antibody-drug Conjugate (ADC) Payload Market Size & Forecast
1.5.1 Global Antibody-drug Conjugate (ADC) Payload Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Antibody-drug Conjugate (ADC) Payload Sales Quantity (2020-2031)
1.5.3 Global Antibody-drug Conjugate (ADC) Payload Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Antibody-drug Conjugate (ADC) Payload Product and Services
2.1.4 Lonza Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Lonza Recent Developments/Updates
2.2 Veranova
2.2.1 Veranova Details
2.2.2 Veranova Major Business
2.2.3 Veranova Antibody-drug Conjugate (ADC) Payload Product and Services
2.2.4 Veranova Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Veranova Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Antibody-drug Conjugate (ADC) Payload Product and Services
2.3.4 Merck Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck Recent Developments/Updates
2.4 Cerbios-Pharma SA
2.4.1 Cerbios-Pharma SA Details
2.4.2 Cerbios-Pharma SA Major Business
2.4.3 Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Product and Services
2.4.4 Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Cerbios-Pharma SA Recent Developments/Updates
2.5 Porton Pharma Solutions
2.5.1 Porton Pharma Solutions Details
2.5.2 Porton Pharma Solutions Major Business
2.5.3 Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Product and Services
2.5.4 Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Porton Pharma Solutions Recent Developments/Updates
2.6 Ajinomoto Bio-Pharma
2.6.1 Ajinomoto Bio-Pharma Details
2.6.2 Ajinomoto Bio-Pharma Major Business
2.6.3 Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Product and Services
2.6.4 Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Ajinomoto Bio-Pharma Recent Developments/Updates
2.7 Teva Pharmaceutical Industries Ltd.
2.7.1 Teva Pharmaceutical Industries Ltd. Details
2.7.2 Teva Pharmaceutical Industries Ltd. Major Business
2.7.3 Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Product and Services
2.7.4 Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.8 Abzena
2.8.1 Abzena Details
2.8.2 Abzena Major Business
2.8.3 Abzena Antibody-drug Conjugate (ADC) Payload Product and Services
2.8.4 Abzena Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Abzena Recent Developments/Updates
2.9 Sterling Pharma Solutions Limited
2.9.1 Sterling Pharma Solutions Limited Details
2.9.2 Sterling Pharma Solutions Limited Major Business
2.9.3 Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Product and Services
2.9.4 Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Sterling Pharma Solutions Limited Recent Developments/Updates
2.10 Indena
2.10.1 Indena Details
2.10.2 Indena Major Business
2.10.3 Indena Antibody-drug Conjugate (ADC) Payload Product and Services
2.10.4 Indena Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Indena Recent Developments/Updates
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Antibody-drug Conjugate (ADC) Payload Product and Services
2.11.4 Pfizer Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Pfizer Recent Developments/Updates
2.12 CordenPharma
2.12.1 CordenPharma Details
2.12.2 CordenPharma Major Business
2.12.3 CordenPharma Antibody-drug Conjugate (ADC) Payload Product and Services
2.12.4 CordenPharma Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 CordenPharma Recent Developments/Updates
2.13 Heraeus Precious Metals
2.13.1 Heraeus Precious Metals Details
2.13.2 Heraeus Precious Metals Major Business
2.13.3 Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Product and Services
2.13.4 Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Heraeus Precious Metals Recent Developments/Updates
2.14 Novasep
2.14.1 Novasep Details
2.14.2 Novasep Major Business
2.14.3 Novasep Antibody-drug Conjugate (ADC) Payload Product and Services
2.14.4 Novasep Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Novasep Recent Developments/Updates
2.15 Shanghai Haoyuan Chemexpress Co. Ltd.
2.15.1 Shanghai Haoyuan Chemexpress Co. Ltd. Details
2.15.2 Shanghai Haoyuan Chemexpress Co. Ltd. Major Business
2.15.3 Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Product and Services
2.15.4 Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Shanghai Haoyuan Chemexpress Co. Ltd. Recent Developments/Updates
2.16 Minakem
2.16.1 Minakem Details
2.16.2 Minakem Major Business
2.16.3 Minakem Antibody-drug Conjugate (ADC) Payload Product and Services
2.16.4 Minakem Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Minakem Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTIBODY-DRUG CONJUGATE (ADC) PAYLOAD BY MANUFACTURER
3.1 Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Manufacturer (2020-2025)
3.2 Global Antibody-drug Conjugate (ADC) Payload Revenue by Manufacturer (2020-2025)
3.3 Global Antibody-drug Conjugate (ADC) Payload Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Antibody-drug Conjugate (ADC) Payload by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Antibody-drug Conjugate (ADC) Payload Manufacturer Market Share in 2024
3.4.3 Top 6 Antibody-drug Conjugate (ADC) Payload Manufacturer Market Share in 2024
3.5 Antibody-drug Conjugate (ADC) Payload Market: Overall Company Footprint Analysis
3.5.1 Antibody-drug Conjugate (ADC) Payload Market: Region Footprint
3.5.2 Antibody-drug Conjugate (ADC) Payload Market: Company Product Type Footprint
3.5.3 Antibody-drug Conjugate (ADC) Payload Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Antibody-drug Conjugate (ADC) Payload Market Size by Region
4.1.1 Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2020-2031)
4.1.2 Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2020-2031)
4.1.3 Global Antibody-drug Conjugate (ADC) Payload Average Price by Region (2020-2031)
4.2 North America Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031)
4.3 Europe Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031)
4.4 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031)
4.5 South America Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031)
4.6 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
5.2 Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Type (2020-2031)
5.3 Global Antibody-drug Conjugate (ADC) Payload Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
6.2 Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application (2020-2031)
6.3 Global Antibody-drug Conjugate (ADC) Payload Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
7.2 North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
7.3 North America Antibody-drug Conjugate (ADC) Payload Market Size by Country
7.3.1 North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2031)
7.3.2 North America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
8.2 Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
8.3 Europe Antibody-drug Conjugate (ADC) Payload Market Size by Country
8.3.1 Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2031)
8.3.2 Europe Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Market Size by Region
9.3.1 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
10.2 South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
10.3 South America Antibody-drug Conjugate (ADC) Payload Market Size by Country
10.3.1 South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2031)
10.3.2 South America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Market Size by Country
11.3.1 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Antibody-drug Conjugate (ADC) Payload Market Drivers
12.2 Antibody-drug Conjugate (ADC) Payload Market Restraints
12.3 Antibody-drug Conjugate (ADC) Payload Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Antibody-drug Conjugate (ADC) Payload and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antibody-drug Conjugate (ADC) Payload
13.3 Antibody-drug Conjugate (ADC) Payload Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antibody-drug Conjugate (ADC) Payload Typical Distributors
14.3 Antibody-drug Conjugate (ADC) Payload Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Tumor Specificity
1.3.3 Broadly Targeted
1.4 Market Analysis by Application
1.4.1 Overview: Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceuticals
1.4.3 Scientific Research
1.5 Global Antibody-drug Conjugate (ADC) Payload Market Size & Forecast
1.5.1 Global Antibody-drug Conjugate (ADC) Payload Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Antibody-drug Conjugate (ADC) Payload Sales Quantity (2020-2031)
1.5.3 Global Antibody-drug Conjugate (ADC) Payload Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Antibody-drug Conjugate (ADC) Payload Product and Services
2.1.4 Lonza Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Lonza Recent Developments/Updates
2.2 Veranova
2.2.1 Veranova Details
2.2.2 Veranova Major Business
2.2.3 Veranova Antibody-drug Conjugate (ADC) Payload Product and Services
2.2.4 Veranova Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Veranova Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Antibody-drug Conjugate (ADC) Payload Product and Services
2.3.4 Merck Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck Recent Developments/Updates
2.4 Cerbios-Pharma SA
2.4.1 Cerbios-Pharma SA Details
2.4.2 Cerbios-Pharma SA Major Business
2.4.3 Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Product and Services
2.4.4 Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Cerbios-Pharma SA Recent Developments/Updates
2.5 Porton Pharma Solutions
2.5.1 Porton Pharma Solutions Details
2.5.2 Porton Pharma Solutions Major Business
2.5.3 Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Product and Services
2.5.4 Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Porton Pharma Solutions Recent Developments/Updates
2.6 Ajinomoto Bio-Pharma
2.6.1 Ajinomoto Bio-Pharma Details
2.6.2 Ajinomoto Bio-Pharma Major Business
2.6.3 Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Product and Services
2.6.4 Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Ajinomoto Bio-Pharma Recent Developments/Updates
2.7 Teva Pharmaceutical Industries Ltd.
2.7.1 Teva Pharmaceutical Industries Ltd. Details
2.7.2 Teva Pharmaceutical Industries Ltd. Major Business
2.7.3 Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Product and Services
2.7.4 Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.8 Abzena
2.8.1 Abzena Details
2.8.2 Abzena Major Business
2.8.3 Abzena Antibody-drug Conjugate (ADC) Payload Product and Services
2.8.4 Abzena Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Abzena Recent Developments/Updates
2.9 Sterling Pharma Solutions Limited
2.9.1 Sterling Pharma Solutions Limited Details
2.9.2 Sterling Pharma Solutions Limited Major Business
2.9.3 Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Product and Services
2.9.4 Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Sterling Pharma Solutions Limited Recent Developments/Updates
2.10 Indena
2.10.1 Indena Details
2.10.2 Indena Major Business
2.10.3 Indena Antibody-drug Conjugate (ADC) Payload Product and Services
2.10.4 Indena Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Indena Recent Developments/Updates
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Antibody-drug Conjugate (ADC) Payload Product and Services
2.11.4 Pfizer Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Pfizer Recent Developments/Updates
2.12 CordenPharma
2.12.1 CordenPharma Details
2.12.2 CordenPharma Major Business
2.12.3 CordenPharma Antibody-drug Conjugate (ADC) Payload Product and Services
2.12.4 CordenPharma Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 CordenPharma Recent Developments/Updates
2.13 Heraeus Precious Metals
2.13.1 Heraeus Precious Metals Details
2.13.2 Heraeus Precious Metals Major Business
2.13.3 Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Product and Services
2.13.4 Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Heraeus Precious Metals Recent Developments/Updates
2.14 Novasep
2.14.1 Novasep Details
2.14.2 Novasep Major Business
2.14.3 Novasep Antibody-drug Conjugate (ADC) Payload Product and Services
2.14.4 Novasep Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Novasep Recent Developments/Updates
2.15 Shanghai Haoyuan Chemexpress Co. Ltd.
2.15.1 Shanghai Haoyuan Chemexpress Co. Ltd. Details
2.15.2 Shanghai Haoyuan Chemexpress Co. Ltd. Major Business
2.15.3 Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Product and Services
2.15.4 Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Shanghai Haoyuan Chemexpress Co. Ltd. Recent Developments/Updates
2.16 Minakem
2.16.1 Minakem Details
2.16.2 Minakem Major Business
2.16.3 Minakem Antibody-drug Conjugate (ADC) Payload Product and Services
2.16.4 Minakem Antibody-drug Conjugate (ADC) Payload Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Minakem Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTIBODY-DRUG CONJUGATE (ADC) PAYLOAD BY MANUFACTURER
3.1 Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Manufacturer (2020-2025)
3.2 Global Antibody-drug Conjugate (ADC) Payload Revenue by Manufacturer (2020-2025)
3.3 Global Antibody-drug Conjugate (ADC) Payload Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Antibody-drug Conjugate (ADC) Payload by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Antibody-drug Conjugate (ADC) Payload Manufacturer Market Share in 2024
3.4.3 Top 6 Antibody-drug Conjugate (ADC) Payload Manufacturer Market Share in 2024
3.5 Antibody-drug Conjugate (ADC) Payload Market: Overall Company Footprint Analysis
3.5.1 Antibody-drug Conjugate (ADC) Payload Market: Region Footprint
3.5.2 Antibody-drug Conjugate (ADC) Payload Market: Company Product Type Footprint
3.5.3 Antibody-drug Conjugate (ADC) Payload Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Antibody-drug Conjugate (ADC) Payload Market Size by Region
4.1.1 Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2020-2031)
4.1.2 Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2020-2031)
4.1.3 Global Antibody-drug Conjugate (ADC) Payload Average Price by Region (2020-2031)
4.2 North America Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031)
4.3 Europe Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031)
4.4 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031)
4.5 South America Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031)
4.6 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
5.2 Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Type (2020-2031)
5.3 Global Antibody-drug Conjugate (ADC) Payload Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
6.2 Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application (2020-2031)
6.3 Global Antibody-drug Conjugate (ADC) Payload Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
7.2 North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
7.3 North America Antibody-drug Conjugate (ADC) Payload Market Size by Country
7.3.1 North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2031)
7.3.2 North America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
8.2 Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
8.3 Europe Antibody-drug Conjugate (ADC) Payload Market Size by Country
8.3.1 Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2031)
8.3.2 Europe Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Market Size by Region
9.3.1 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
10.2 South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
10.3 South America Antibody-drug Conjugate (ADC) Payload Market Size by Country
10.3.1 South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2031)
10.3.2 South America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Market Size by Country
11.3.1 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Antibody-drug Conjugate (ADC) Payload Market Drivers
12.2 Antibody-drug Conjugate (ADC) Payload Market Restraints
12.3 Antibody-drug Conjugate (ADC) Payload Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Antibody-drug Conjugate (ADC) Payload and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antibody-drug Conjugate (ADC) Payload
13.3 Antibody-drug Conjugate (ADC) Payload Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antibody-drug Conjugate (ADC) Payload Typical Distributors
14.3 Antibody-drug Conjugate (ADC) Payload Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF FIGURES
Table 1. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Lonza Basic Information, Manufacturing Base and Competitors
Table 4. Lonza Major Business
Table 5. Lonza Antibody-drug Conjugate (ADC) Payload Product and Services
Table 6. Lonza Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Lonza Recent Developments/Updates
Table 8. Veranova Basic Information, Manufacturing Base and Competitors
Table 9. Veranova Major Business
Table 10. Veranova Antibody-drug Conjugate (ADC) Payload Product and Services
Table 11. Veranova Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Veranova Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Antibody-drug Conjugate (ADC) Payload Product and Services
Table 16. Merck Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Merck Recent Developments/Updates
Table 18. Cerbios-Pharma SA Basic Information, Manufacturing Base and Competitors
Table 19. Cerbios-Pharma SA Major Business
Table 20. Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Product and Services
Table 21. Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Cerbios-Pharma SA Recent Developments/Updates
Table 23. Porton Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 24. Porton Pharma Solutions Major Business
Table 25. Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Product and Services
Table 26. Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Porton Pharma Solutions Recent Developments/Updates
Table 28. Ajinomoto Bio-Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Ajinomoto Bio-Pharma Major Business
Table 30. Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Product and Services
Table 31. Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Ajinomoto Bio-Pharma Recent Developments/Updates
Table 33. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Teva Pharmaceutical Industries Ltd. Major Business
Table 35. Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Product and Services
Table 36. Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 38. Abzena Basic Information, Manufacturing Base and Competitors
Table 39. Abzena Major Business
Table 40. Abzena Antibody-drug Conjugate (ADC) Payload Product and Services
Table 41. Abzena Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Abzena Recent Developments/Updates
Table 43. Sterling Pharma Solutions Limited Basic Information, Manufacturing Base and Competitors
Table 44. Sterling Pharma Solutions Limited Major Business
Table 45. Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Product and Services
Table 46. Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Sterling Pharma Solutions Limited Recent Developments/Updates
Table 48. Indena Basic Information, Manufacturing Base and Competitors
Table 49. Indena Major Business
Table 50. Indena Antibody-drug Conjugate (ADC) Payload Product and Services
Table 51. Indena Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Indena Recent Developments/Updates
Table 53. Pfizer Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Major Business
Table 55. Pfizer Antibody-drug Conjugate (ADC) Payload Product and Services
Table 56. Pfizer Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Pfizer Recent Developments/Updates
Table 58. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 59. CordenPharma Major Business
Table 60. CordenPharma Antibody-drug Conjugate (ADC) Payload Product and Services
Table 61. CordenPharma Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. CordenPharma Recent Developments/Updates
Table 63. Heraeus Precious Metals Basic Information, Manufacturing Base and Competitors
Table 64. Heraeus Precious Metals Major Business
Table 65. Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Product and Services
Table 66. Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Heraeus Precious Metals Recent Developments/Updates
Table 68. Novasep Basic Information, Manufacturing Base and Competitors
Table 69. Novasep Major Business
Table 70. Novasep Antibody-drug Conjugate (ADC) Payload Product and Services
Table 71. Novasep Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Novasep Recent Developments/Updates
Table 73. Shanghai Haoyuan Chemexpress Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Shanghai Haoyuan Chemexpress Co. Ltd. Major Business
Table 75. Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Product and Services
Table 76. Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Shanghai Haoyuan Chemexpress Co. Ltd. Recent Developments/Updates
Table 78. Minakem Basic Information, Manufacturing Base and Competitors
Table 79. Minakem Major Business
Table 80. Minakem Antibody-drug Conjugate (ADC) Payload Product and Services
Table 81. Minakem Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Minakem Recent Developments/Updates
Table 83. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Manufacturer (2020-2025) & (kg)
Table 84. Global Antibody-drug Conjugate (ADC) Payload Revenue by Manufacturer (2020-2025) & (USD Million)
Table 85. Global Antibody-drug Conjugate (ADC) Payload Average Price by Manufacturer (2020-2025) & (US$/g)
Table 86. Market Position of Manufacturers in Antibody-drug Conjugate (ADC) Payload, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 87. Head Office and Antibody-drug Conjugate (ADC) Payload Production Site of Key Manufacturer
Table 88. Antibody-drug Conjugate (ADC) Payload Market: Company Product Type Footprint
Table 89. Antibody-drug Conjugate (ADC) Payload Market: Company Product Application Footprint
Table 90. Antibody-drug Conjugate (ADC) Payload New Market Entrants and Barriers to Market Entry
Table 91. Antibody-drug Conjugate (ADC) Payload Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 93. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2020-2025) & (kg)
Table 94. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2026-2031) & (kg)
Table 95. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2020-2025) & (USD Million)
Table 96. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2026-2031) & (USD Million)
Table 97. Global Antibody-drug Conjugate (ADC) Payload Average Price by Region (2020-2025) & (US$/g)
Table 98. Global Antibody-drug Conjugate (ADC) Payload Average Price by Region (2026-2031) & (US$/g)
Table 99. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 100. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 101. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Type (2020-2025) & (USD Million)
Table 102. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Type (2026-2031) & (USD Million)
Table 103. Global Antibody-drug Conjugate (ADC) Payload Average Price by Type (2020-2025) & (US$/g)
Table 104. Global Antibody-drug Conjugate (ADC) Payload Average Price by Type (2026-2031) & (US$/g)
Table 105. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 106. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 107. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application (2020-2025) & (USD Million)
Table 108. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application (2026-2031) & (USD Million)
Table 109. Global Antibody-drug Conjugate (ADC) Payload Average Price by Application (2020-2025) & (US$/g)
Table 110. Global Antibody-drug Conjugate (ADC) Payload Average Price by Application (2026-2031) & (US$/g)
Table 111. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 112. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 113. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 114. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 115. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2025) & (kg)
Table 116. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2026-2031) & (kg)
Table 117. North America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2025) & (USD Million)
Table 118. North America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2026-2031) & (USD Million)
Table 119. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 120. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 121. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 122. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 123. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2025) & (kg)
Table 124. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2026-2031) & (kg)
Table 125. Europe Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2025) & (USD Million)
Table 126. Europe Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 128. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 129. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 130. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 131. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2020-2025) & (kg)
Table 132. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2026-2031) & (kg)
Table 133. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2020-2025) & (USD Million)
Table 134. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2026-2031) & (USD Million)
Table 135. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 136. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 137. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 138. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 139. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2025) & (kg)
Table 140. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2026-2031) & (kg)
Table 141. South America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2025) & (USD Million)
Table 142. South America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2026-2031) & (USD Million)
Table 143. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 144. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 145. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 146. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 147. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2025) & (kg)
Table 148. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2026-2031) & (kg)
Table 149. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2025) & (USD Million)
Table 150. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2026-2031) & (USD Million)
Table 151. Antibody-drug Conjugate (ADC) Payload Raw Material
Table 152. Key Manufacturers of Antibody-drug Conjugate (ADC) Payload Raw Materials
Table 153. Antibody-drug Conjugate (ADC) Payload Typical Distributors
Table 154. Antibody-drug Conjugate (ADC) Payload Typical Customers
LIST OF FIGURES
Figure 1. Antibody-drug Conjugate (ADC) Payload Picture
Figure 2. Global Antibody-drug Conjugate (ADC) Payload Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Type in 2024
Figure 4. Tumor Specificity Examples
Figure 5. Broadly Targeted Examples
Figure 6. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Application in 2024
Figure 8. Pharmaceuticals Examples
Figure 9. Scientific Research Examples
Figure 10. Global Antibody-drug Conjugate (ADC) Payload Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Antibody-drug Conjugate (ADC) Payload Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity (2020-2031) & (kg)
Figure 13. Global Antibody-drug Conjugate (ADC) Payload Price (2020-2031) & (US$/g)
Figure 14. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of Antibody-drug Conjugate (ADC) Payload by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 Antibody-drug Conjugate (ADC) Payload Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 Antibody-drug Conjugate (ADC) Payload Manufacturer (Revenue) Market Share in 2024
Figure 19. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Region (2020-2031)
Figure 21. North America Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 24. South America Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 26. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Type (2020-2031)
Figure 28. Global Antibody-drug Conjugate (ADC) Payload Average Price by Type (2020-2031) & (US$/g)
Figure 29. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Application (2020-2031)
Figure 31. Global Antibody-drug Conjugate (ADC) Payload Average Price by Application (2020-2031) & (US$/g)
Figure 32. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 44. France Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Region (2020-2031)
Figure 52. China Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 55. India Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 72. Antibody-drug Conjugate (ADC) Payload Market Drivers
Figure 73. Antibody-drug Conjugate (ADC) Payload Market Restraints
Figure 74. Antibody-drug Conjugate (ADC) Payload Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Antibody-drug Conjugate (ADC) Payload in 2024
Figure 77. Manufacturing Process Analysis of Antibody-drug Conjugate (ADC) Payload
Figure 78. Antibody-drug Conjugate (ADC) Payload Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Table 1. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Lonza Basic Information, Manufacturing Base and Competitors
Table 4. Lonza Major Business
Table 5. Lonza Antibody-drug Conjugate (ADC) Payload Product and Services
Table 6. Lonza Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Lonza Recent Developments/Updates
Table 8. Veranova Basic Information, Manufacturing Base and Competitors
Table 9. Veranova Major Business
Table 10. Veranova Antibody-drug Conjugate (ADC) Payload Product and Services
Table 11. Veranova Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Veranova Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Antibody-drug Conjugate (ADC) Payload Product and Services
Table 16. Merck Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Merck Recent Developments/Updates
Table 18. Cerbios-Pharma SA Basic Information, Manufacturing Base and Competitors
Table 19. Cerbios-Pharma SA Major Business
Table 20. Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Product and Services
Table 21. Cerbios-Pharma SA Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Cerbios-Pharma SA Recent Developments/Updates
Table 23. Porton Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 24. Porton Pharma Solutions Major Business
Table 25. Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Product and Services
Table 26. Porton Pharma Solutions Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Porton Pharma Solutions Recent Developments/Updates
Table 28. Ajinomoto Bio-Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Ajinomoto Bio-Pharma Major Business
Table 30. Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Product and Services
Table 31. Ajinomoto Bio-Pharma Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Ajinomoto Bio-Pharma Recent Developments/Updates
Table 33. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Teva Pharmaceutical Industries Ltd. Major Business
Table 35. Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Product and Services
Table 36. Teva Pharmaceutical Industries Ltd. Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 38. Abzena Basic Information, Manufacturing Base and Competitors
Table 39. Abzena Major Business
Table 40. Abzena Antibody-drug Conjugate (ADC) Payload Product and Services
Table 41. Abzena Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Abzena Recent Developments/Updates
Table 43. Sterling Pharma Solutions Limited Basic Information, Manufacturing Base and Competitors
Table 44. Sterling Pharma Solutions Limited Major Business
Table 45. Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Product and Services
Table 46. Sterling Pharma Solutions Limited Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Sterling Pharma Solutions Limited Recent Developments/Updates
Table 48. Indena Basic Information, Manufacturing Base and Competitors
Table 49. Indena Major Business
Table 50. Indena Antibody-drug Conjugate (ADC) Payload Product and Services
Table 51. Indena Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Indena Recent Developments/Updates
Table 53. Pfizer Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Major Business
Table 55. Pfizer Antibody-drug Conjugate (ADC) Payload Product and Services
Table 56. Pfizer Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Pfizer Recent Developments/Updates
Table 58. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 59. CordenPharma Major Business
Table 60. CordenPharma Antibody-drug Conjugate (ADC) Payload Product and Services
Table 61. CordenPharma Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. CordenPharma Recent Developments/Updates
Table 63. Heraeus Precious Metals Basic Information, Manufacturing Base and Competitors
Table 64. Heraeus Precious Metals Major Business
Table 65. Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Product and Services
Table 66. Heraeus Precious Metals Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Heraeus Precious Metals Recent Developments/Updates
Table 68. Novasep Basic Information, Manufacturing Base and Competitors
Table 69. Novasep Major Business
Table 70. Novasep Antibody-drug Conjugate (ADC) Payload Product and Services
Table 71. Novasep Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Novasep Recent Developments/Updates
Table 73. Shanghai Haoyuan Chemexpress Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Shanghai Haoyuan Chemexpress Co. Ltd. Major Business
Table 75. Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Product and Services
Table 76. Shanghai Haoyuan Chemexpress Co. Ltd. Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Shanghai Haoyuan Chemexpress Co. Ltd. Recent Developments/Updates
Table 78. Minakem Basic Information, Manufacturing Base and Competitors
Table 79. Minakem Major Business
Table 80. Minakem Antibody-drug Conjugate (ADC) Payload Product and Services
Table 81. Minakem Antibody-drug Conjugate (ADC) Payload Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Minakem Recent Developments/Updates
Table 83. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Manufacturer (2020-2025) & (kg)
Table 84. Global Antibody-drug Conjugate (ADC) Payload Revenue by Manufacturer (2020-2025) & (USD Million)
Table 85. Global Antibody-drug Conjugate (ADC) Payload Average Price by Manufacturer (2020-2025) & (US$/g)
Table 86. Market Position of Manufacturers in Antibody-drug Conjugate (ADC) Payload, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 87. Head Office and Antibody-drug Conjugate (ADC) Payload Production Site of Key Manufacturer
Table 88. Antibody-drug Conjugate (ADC) Payload Market: Company Product Type Footprint
Table 89. Antibody-drug Conjugate (ADC) Payload Market: Company Product Application Footprint
Table 90. Antibody-drug Conjugate (ADC) Payload New Market Entrants and Barriers to Market Entry
Table 91. Antibody-drug Conjugate (ADC) Payload Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 93. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2020-2025) & (kg)
Table 94. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2026-2031) & (kg)
Table 95. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2020-2025) & (USD Million)
Table 96. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2026-2031) & (USD Million)
Table 97. Global Antibody-drug Conjugate (ADC) Payload Average Price by Region (2020-2025) & (US$/g)
Table 98. Global Antibody-drug Conjugate (ADC) Payload Average Price by Region (2026-2031) & (US$/g)
Table 99. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 100. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 101. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Type (2020-2025) & (USD Million)
Table 102. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Type (2026-2031) & (USD Million)
Table 103. Global Antibody-drug Conjugate (ADC) Payload Average Price by Type (2020-2025) & (US$/g)
Table 104. Global Antibody-drug Conjugate (ADC) Payload Average Price by Type (2026-2031) & (US$/g)
Table 105. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 106. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 107. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application (2020-2025) & (USD Million)
Table 108. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application (2026-2031) & (USD Million)
Table 109. Global Antibody-drug Conjugate (ADC) Payload Average Price by Application (2020-2025) & (US$/g)
Table 110. Global Antibody-drug Conjugate (ADC) Payload Average Price by Application (2026-2031) & (US$/g)
Table 111. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 112. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 113. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 114. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 115. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2025) & (kg)
Table 116. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2026-2031) & (kg)
Table 117. North America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2025) & (USD Million)
Table 118. North America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2026-2031) & (USD Million)
Table 119. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 120. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 121. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 122. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 123. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2025) & (kg)
Table 124. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2026-2031) & (kg)
Table 125. Europe Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2025) & (USD Million)
Table 126. Europe Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 128. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 129. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 130. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 131. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2020-2025) & (kg)
Table 132. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity by Region (2026-2031) & (kg)
Table 133. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2020-2025) & (USD Million)
Table 134. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value by Region (2026-2031) & (USD Million)
Table 135. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 136. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 137. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 138. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 139. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2025) & (kg)
Table 140. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2026-2031) & (kg)
Table 141. South America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2025) & (USD Million)
Table 142. South America Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2026-2031) & (USD Million)
Table 143. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2020-2025) & (kg)
Table 144. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Type (2026-2031) & (kg)
Table 145. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2020-2025) & (kg)
Table 146. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Application (2026-2031) & (kg)
Table 147. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2020-2025) & (kg)
Table 148. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity by Country (2026-2031) & (kg)
Table 149. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2020-2025) & (USD Million)
Table 150. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value by Country (2026-2031) & (USD Million)
Table 151. Antibody-drug Conjugate (ADC) Payload Raw Material
Table 152. Key Manufacturers of Antibody-drug Conjugate (ADC) Payload Raw Materials
Table 153. Antibody-drug Conjugate (ADC) Payload Typical Distributors
Table 154. Antibody-drug Conjugate (ADC) Payload Typical Customers
LIST OF FIGURES
Figure 1. Antibody-drug Conjugate (ADC) Payload Picture
Figure 2. Global Antibody-drug Conjugate (ADC) Payload Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Type in 2024
Figure 4. Tumor Specificity Examples
Figure 5. Broadly Targeted Examples
Figure 6. Global Antibody-drug Conjugate (ADC) Payload Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Application in 2024
Figure 8. Pharmaceuticals Examples
Figure 9. Scientific Research Examples
Figure 10. Global Antibody-drug Conjugate (ADC) Payload Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Antibody-drug Conjugate (ADC) Payload Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity (2020-2031) & (kg)
Figure 13. Global Antibody-drug Conjugate (ADC) Payload Price (2020-2031) & (US$/g)
Figure 14. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of Antibody-drug Conjugate (ADC) Payload by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 Antibody-drug Conjugate (ADC) Payload Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 Antibody-drug Conjugate (ADC) Payload Manufacturer (Revenue) Market Share in 2024
Figure 19. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Region (2020-2031)
Figure 21. North America Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 24. South America Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 26. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Type (2020-2031)
Figure 28. Global Antibody-drug Conjugate (ADC) Payload Average Price by Type (2020-2031) & (US$/g)
Figure 29. Global Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global Antibody-drug Conjugate (ADC) Payload Revenue Market Share by Application (2020-2031)
Figure 31. Global Antibody-drug Conjugate (ADC) Payload Average Price by Application (2020-2031) & (US$/g)
Figure 32. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 44. France Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Region (2020-2031)
Figure 52. China Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 55. India Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa Antibody-drug Conjugate (ADC) Payload Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa Antibody-drug Conjugate (ADC) Payload Consumption Value (2020-2031) & (USD Million)
Figure 72. Antibody-drug Conjugate (ADC) Payload Market Drivers
Figure 73. Antibody-drug Conjugate (ADC) Payload Market Restraints
Figure 74. Antibody-drug Conjugate (ADC) Payload Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Antibody-drug Conjugate (ADC) Payload in 2024
Figure 77. Manufacturing Process Analysis of Antibody-drug Conjugate (ADC) Payload
Figure 78. Antibody-drug Conjugate (ADC) Payload Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
